Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Lymphoma
Related studies linked through entity extraction aliases.
Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-427 When Given to Patients With Advanced and Refractory Solid Tumors or Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
Cardiac Fibrosis by CMR in Patients With Cancer
- Status
- WITHDRAWN
- Phase
- N/A
Phase I Dose-finding and Preliminary Efficacy Study of the Istodax® in Combination With Doxil® for the Treatment of Adults With Relapsed or Refractory Cutaneous T-cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Study of Rituximab and Brentuximab Vedotin for Relapsed Classical Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
Food Effect Study of Alisertib (MLN8237) in Participants With Advanced Solid Tumors or Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
Acupuncture for Chemotherapy-induced Peripheral Neuropathy
- Status
- UNKNOWN
- Phase
- NA
Evaluation of Immunological Reconstitution After Haploidentical Bone Marrow Transplantation
- Status
- UNKNOWN
- Phase
- N/A
A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Rituximab (MabThera/Rituxan) in Participants With Diffuse Large B Cell Lymphoma (DLBCL) or Follicular Lymphoma (FL)
- Status
- COMPLETED
- Phase
- PHASE3
IL-15 Super Agonist ALT-803 to Treat Relapse Of Hematologic Malignancy After Allogeneic SCT
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A RETROspective Data Collection of comPRESSion Anastomosis Using the ColonRing
- Status
- UNKNOWN
- Phase
- N/A
A Multiple Ascending Dose Study of Milademetan in Subjects With Advanced Solid Tumors or Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
Samsung Medical Center-Lymphoma Cohort Study-II
- Status
- COMPLETED
- Phase
- N/A
Study of IPI-145 in Combination With Rituximab or Bendamustine/Rituximab in Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
A Study of the Bruton's Tyrosine Kinase Inhibitor, PCI-32765 (Ibrutinib), in Combination With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Non-Germinal Center B-Cell Subtype of Diffuse Large B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
PENELOPE Observational Study: Prophylaxis and Treatment of Arterial and Venous Thromboembolism
- Status
- COMPLETED
- Phase
- N/A
Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related Pain
- Status
- TERMINATED
- Phase
- PHASE1
Safety, Tolerability and Pharmacokinetic (PK) of Concomitant Esomeprazole and Rifampin, and QT Study on Single and Multiple-doses of Alisertib
- Status
- COMPLETED
- Phase
- PHASE1
Evolution of Bone Mineral Density (BMD) in Patients With Lymphoma Undergoing Chemotherapy
- Status
- WITHDRAWN
- Phase
- PHASE4
Feasibility of Assessing Lymphoma Response to Precise Local Injection of Candidate Chemotherapy Agents
- Status
- COMPLETED
- Phase
- PHASE1